Publications by authors named "Esha Cyril"
Article Synopsis
- Rare diseases, or orphan diseases, are rare conditions with limited occurrence, making the development of treatments (orphan drugs) difficult due to scarce resources and challenges in clinical trials.
- Advances in genomic technologies and regulatory frameworks have led to some successful orphan drug approvals, particularly in the U.S., which has improved the landscape for these drugs.
- In India, despite recent policy changes that aim to improve the rare disease ecosystem, there is still a lack of clear guidelines for orphan drug development, necessitating collaboration among government, industries, and patient advocates to enhance the process.
